1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Non-invasive Aesthetic Treatment Market, by Type
6.1. Introduction
6.2. Injectable
6.3. Others
6.4. Skin Rejuvenation

7. Non-invasive Aesthetic Treatment Market, by Procedure
7.1. Introduction
7.2. Injectables
7.3. Skin Rejuvenation

8. Non-invasive Aesthetic Treatment Market, by End User
8.1. Introduction
8.2. Dermatology Clinics & Cosmetic Centers Salons & Spas
8.3. Hospitals & Clinics
8.4. Others

9. California Non-invasive Aesthetic Treatment Market

10. Florida Non-invasive Aesthetic Treatment Market

11. Illinois Non-invasive Aesthetic Treatment Market

12. New York Non-invasive Aesthetic Treatment Market

13. Ohio Non-invasive Aesthetic Treatment Market

14. Pennsylvania Non-invasive Aesthetic Treatment Market

15. Texas Non-invasive Aesthetic Treatment Market

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Allergan, Inc.
17.2. Alma Lasers
17.3. Cutera Inc.
17.4. Galderma S.A.
17.5. Hologic, Inc.
17.6. Johnson & Johnson
17.7. Lumenis
17.8. Merz Pharma
17.9. Revance Therapeutics Inc.
17.10. Solta Medical
17.11. Syneron Candela

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY TYPE, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY TYPE, 2027
FIGURE 6. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY INJECTABLE, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY SKIN REJUVENATION, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY SKIN REJUVENATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY PROCEDURE, 2020 VS 2027 (%)
FIGURE 13. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY PROCEDURE, 2020 VS 2027 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY PROCEDURE, 2027
FIGURE 15. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY INJECTABLES, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY INJECTABLES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY SKIN REJUVENATION, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY SKIN REJUVENATION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY END USER, 2020 VS 2027 (%)
FIGURE 20. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY END USER, 2020 VS 2027 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY END USER, 2027
FIGURE 22. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS & COSMETIC CENTERS SALONS & SPAS, 2018-2027 (USD MILLION)
FIGURE 23. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS & COSMETIC CENTERS SALONS & SPAS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2027 (USD MILLION)
FIGURE 25. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 26. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY OTHERS, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 28. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 29. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 30. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY INJECTABLE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY SKIN REJUVENATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY PROCEDURE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY INJECTABLES, BY STATE, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY SKIN REJUVENATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY END USER, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS & COSMETIC CENTERS SALONS & SPAS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET SIZE, BY OTHERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: SCORES
TABLE 15. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: BUSINESS STRATEGY
TABLE 16. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 17. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: RANKING
TABLE 18. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 19. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: MERGER & ACQUISITION
TABLE 20. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 21. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 22. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 23. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 24. UNITED STATES NON-INVASIVE AESTHETIC TREATMENT MARKET: LICENSE & PRICING

Companies Mentioned

Allergan, Inc.
Alma Lasers
Cutera Inc.
Galderma S.A.
Hologic, Inc.
Johnson & Johnson
Lumenis
Merz Pharma
Revance Therapeutics Inc.
Solta Medical
Syneron Candela